Trial Profile
Prospective study investigating the impact of lenalidomide maintenance therapy on NK and NK-T polarization and T-cell activation in patients with multiple myeloma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Pharmacodynamics
- 22 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology